Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
revenue growth
Pharma
Pfizer unveils 2026 guidance, triggering 5% share-price decline
With COVID sales falling and patent protections expiring, Pfizer is forecasting its 2026 revenue to be in the range of $59.5 billion to $62.5 billion.
Kevin Dunleavy
Dec 16, 2025 11:19am
Biopharma briefing: Q1 trends, gene therapy news, ASCO preview
May 30, 2025 9:46am
Top 20 pharma companies by 2024 revenue
Apr 21, 2025 3:00am
Most biopharma CEOs expect growth over next 3 years: survey
Nov 27, 2024 8:25am
'The Top Line': A look at pharma revenue rankings
Apr 26, 2024 7:00am
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am
